
U.S. stock futures were mostly lower this morning, with the Dow futures falling around 0.2% on Thursday.
Shares of Abbott Laboratories (NYSE:ABT) fell sharply in pre-market trading after the company issued third-quarter adjusted EPS guidance below estimates.